The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 28, 2011
Filed:
Jul. 14, 2008
Raymond D. Skwierczynski, Oakdale, MN (US);
Terri F. Busch, St. Paul, MN (US);
Amy L. Gust-heiting, Hudson, WI (US);
Mary Fretland, Eagan, MN (US);
Matthew T. Scholz, Woodbury, MN (US);
Raymond D. Skwierczynski, Oakdale, MN (US);
Terri F. Busch, St. Paul, MN (US);
Amy L. Gust-Heiting, Hudson, WI (US);
Mary Fretland, Eagan, MN (US);
Matthew T. Scholz, Woodbury, MN (US);
3M Innovative Properties Company, St. Paul, MN (US);
Abstract
Pharmaceutical formulations comprising an immune response modifier (IRM) chosen from imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo-quinolineamines, oxazolo-quinolinamines, thiazolo-pyridinamines, oxazolo-pyridinamines, imidazonaphthyridine amines, tetrahydroimidazonaphthyridine amines, and thiazolonaphthyridine amines; a fatty acid; and a hydrophobic, aprotic component miscible with the fatty acid are useful for the treatment of dermal associated conditions. Novel topical formulations are provided. In one embodiment, the topical formulations are advantageous for treatment of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.